Nissay Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.36M | Sell |
26,155
-9,306
| -26% | -$854K | 0.01% | 471 |
|
|
2025
Q4 | $3.19M | Buy |
35,461
+429
| +1% | +$40.7K | 0.02% | 405 |
|
|
2025
Q3 | $3.45M | Buy |
35,032
+215
| +0.6% | +$21.3K | 0.02% | 383 |
|
|
2025
Q2 | $3.18M | Buy |
34,817
+271
| +0.8% | +$26.2K | 0.02% | 407 |
|
|
2025
Q1 | $3.91M | Sell |
34,546
-267
| -0.8% | -$28.6K | 0.03% | 358 |
|
|
2024
Q4 | $3.72M | Sell |
34,813
-3,375
| -9% | -$362K | 0.02% | 378 |
|
|
2024
Q3 | $4.12M | Buy |
38,188
+4,339
| +13% | +$474K | 0.03% | 361 |
|
|
2024
Q2 | $3.67M | Buy |
33,849
+245
| +0.7% | +$28.9K | 0.02% | 357 |
|
|
2024
Q1 | $4.44M | Buy |
33,604
+110
| +0.3% | +$13.7K | 0.03% | 326 |
|
|
2023
Q4 | $4.08M | Buy |
33,494
+991
| +3% | +$111K | 0.03% | 308 |
|
|
2023
Q3 | $3.65M | Buy |
32,503
+703
| +2% | +$89.3K | 0.03% | 302 |
|
|
2023
Q2 | $4.63M | Buy |
31,800
+3,596
| +13% | +$489K | 0.04% | 252 |
|
|
2023
Q1 | $3.64M | Buy |
28,204
+3,578
| +15% | +$449K | 0.03% | 298 |
|
|
2022
Q4 | $3.14M | Sell |
24,626
-182
| -0.7% | -$21.1K | 0.03% | 321 |
|
|
2022
Q3 | $2.59M | Buy |
24,808
+998
| +4% | +$110K | 0.03% | 348 |
|
|
2022
Q2 | $2.5M | Buy |
23,810
+10
| +0% | +$1.19K | 0.02% | 361 |
|
|
2022
Q1 | $3.04M | Sell |
23,800
-163
| -0.7% | -$19.6K | 0.03% | 362 |
|
|
2021
Q4 | $2.96M | Buy |
23,963
+971
| +4% | +$127K | 0.02% | 384 |
|
|
2021
Q3 | $3.27M | Buy |
22,992
+977
| +4% | +$144K | 0.03% | 344 |
|
|
2021
Q2 | $3.44M | Sell |
22,015
-209
| -0.9% | -$33.9K | 0.03% | 324 |
|
|
2021
Q1 | $3.45M | Sell |
22,224
-505
| -2% | -$78.2K | 0.03% | 300 |
|
|
2020
Q4 | $3.4M | Sell |
22,729
-166
| -0.7% | -$23.4K | 0.05% | 283 |
|
|
2020
Q3 | $3.03M | Sell |
22,895
-5,681
| -20% | -$742K | 0.05% | 267 |
|
|
2020
Q2 | $3.31M | Buy |
28,576
+599
| +2% | +$69K | 0.06% | 268 |
|
|
2020
Q1 | $2.75M | Buy |
27,977
+1,074
| +4% | +$141K | 0.07% | 260 |
|
|
2019
Q4 | $3.91M | Sell |
26,903
-1,412
| -5% | -$195K | 0.09% | 250 |
|
|
2019
Q3 | $3.77M | Buy |
28,315
+1,066
| +4% | +$138K | 0.09% | 246 |
|
|
2019
Q2 | $3.12M | Sell |
27,249
-979
| -3% | -$115K | 0.08% | 283 |
|
|
2019
Q1 | $3.5M | Sell |
28,228
-2,643
| -9% | -$300K | 0.09% | 254 |
|
|
2018
Q4 | $3.11M | Buy |
30,871
+385
| +1% | +$43.3K | 0.09% | 258 |
|
|
2018
Q3 | $3.89M | Buy |
30,486
+257
| +0.9% | +$30.6K | 0.1% | 236 |
|
|
2018
Q2 | $3.27M | Buy |
30,229
+506
| +2% | +$55.1K | 0.1% | 255 |
|
|
2018
Q1 | $3.15M | Sell |
29,723
-2,940
| -9% | -$341K | 0.1% | 256 |
|
|
2017
Q4 | $3.83M | Buy |
+32,663
| New | +$3.69M | 0.12% | 221 |
|
Other funds holding ZBH
VCM
VPM
Nissay Asset Management's ZBH Position: Q1 2026 in Review
Nissay Asset Management reduced its Zimmer Biomet (ZBH) stake by 26% in Q1 2026, selling an estimated $854K and leaving 26,155 shares worth $2.36M. The position accounts for 0.01% of the portfolio, ranked #471.
Nissay Asset Management first reported a position in ZBH in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.63M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Nissay Asset Management held 26,155 shares of Zimmer Biomet worth $2.36M as of Q1 2026.
- Nissay Asset Management sold 9,306 Zimmer Biomet shares in Q1 2026, an estimated $854K.
- Zimmer Biomet made up 0.01% of Nissay Asset Management's portfolio in Q1 2026, its #471 holding.
- Nissay Asset Management first reported a position in Zimmer Biomet in Q4 2017 and has held it in 34 quarters since.
- Nissay Asset Management's Zimmer Biomet position peaked at $4.63M in Q2 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Nissay Asset Management's 13F filing for Q1 2026, filed 15 May 2026.